To validate ITGB1 as a key mediator of SCLC migration and invasion, we carried out an in vivo approach with different routes of tumor cell injection, either orthotopically into the lungs and i.v. to explore ITGB1-KO effects on intra- and extravasation capacity of tumor cells. This evidence concerns the gene ITGB1 and small cell lung carcinoma.